APA

Sayer R. A., Lancaster J. M., Pittman J., Gray J., Whitaker R., Marks J. R. & Berchuck A. (20050303). High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. : Gynecologic oncology.

Chicago

Sayer Robyn A, Lancaster Johnathan M, Pittman Jennifer, Gray Jonathon, Whitaker Regina, Marks Jeffrey R and Berchuck Andrew. 20050303. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. : Gynecologic oncology.

Harvard

Sayer R. A., Lancaster J. M., Pittman J., Gray J., Whitaker R., Marks J. R. and Berchuck A. (20050303). High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. : Gynecologic oncology.

MLA

Sayer Robyn A, Lancaster Johnathan M, Pittman Jennifer, Gray Jonathon, Whitaker Regina, Marks Jeffrey R and Berchuck Andrew. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. : Gynecologic oncology. 20050303.